Journal article

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease

H Hall, S Reyes, N Landeck, C Bye, G Leanza, K Double, L Thompson, G Halliday, D Kirik

Brain | OXFORD UNIV PRESS | Published : 2014

Abstract

The neuropathological substrate of dementia in patients with Parkinson's disease is still under debate, particularly in patients with insufficient alternate neuropathology for other degenerative dementias. In patients with pure Lewy body Parkinson's disease, previous post-mortem studies have shown that dopaminergic and cholinergic regulatory projection systems degenerate, but the exact pathways that may explain the development of dementia in patients with Parkinson's disease remain unclear. Studies in rodents suggest that both the mesocorticolimbic dopaminergic and septohippocampal cholinergic pathways may functionally interact to regulate certain aspects of cognition, however, whether such ..

View full abstract

University of Melbourne Researchers

Grants


Funding Acknowledgements

This study was supported by grants from the European Research Council (TreatPD 242932), the Swedish Research Council (2008-3092, 2009-2318) and the Swedish Foundation for Strategic Research (Parkinson's models for translational research). Glenda Halliday is a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia. Lachlan Thompson holds a Career Development Fellowship and Chris Bye a Peter Doherty Fellowship - both through the National Health and Medical Research Council of Australia.